Flyer

Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 19
  • Journal CiteScore: 5.42
  • Journal Impact Factor: 4.64
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Articles published in Annals of Clinical and Laboratory Research have been cited by esteemed scholars and scientists all around the world. Annals of Clinical and Laboratory Research has got h-index 19, which means every article in Annals of Clinical and Laboratory Research has got 19 average citations.

Following are the list of articles that have cited the articles published in Annals of Clinical and Laboratory Research.

  2022 2021 2020 2019 2018

Total published articles

60 51 27 33 56

Conference proceedings

0 0 0 24 0

Citations received as per Google Scholar, other indexing platforms and portals

253 265 237 166 105
Journal total citations count 1577
Journal impact factor 4.64
Journal 5 years impact factor 5.34
Journal cite score 5.42
Journal h-index 19
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Paul, E., Kiwelu, I., Mmbaga, B., Nazareth, R., Sabuni, E., Maro, A., ... & Chilongola, J. (2018). Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania. Tropical medicine and health, 46(1), 1-8.
Paul, E., Kiwelu, I., Mmbaga, B., Nazareth, R., Sabuni, E., Maro, A., ... & Chilongola, J. (2018). Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania. Tropical medicine and health, 46(1), 1-8.
Wang, Y., & Yin, H. (2015). Research advances in microneme protein 3 of Toxoplasma gondii. Parasites & vectors, 8(1), 1-12.
Nasir, I. A., Aderinsayo, A. H., Mele, H. U., & Aliyu, M. M. (2015). Prevalence and associated risk factors of Toxoplasma gondii antibodies among pregnant women attending Maiduguri teaching hospital, Nigeria. Journal of Medical Sciences, 15(3), 147.
Abu, E. K., Boampong, J. N., Ayi, I., Ghartey-Kwansah, G., Afoakwah, R., Nsiah, P., & Blay, E. (2015). Infection risk factors associated with seropositivity for Toxoplasma gondii in a population-based study in the Central Region, Ghana. Epidemiology & Infection, 143(9), 1904-1912.
Cong, H., Yuan, Q., Zhao, Q., Zhao, L., Yin, H., Zhou, H., ... & Wang, Z. (2014). Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice. Parasites & vectors, 7(1), 1-8.
Alsammani, M. A. (2016). Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries. Journal of Parasitic Diseases, 40(3), 569-579.
Frimpong, C., Makasa, M., Sitali, L., & Michelo, C. (2017). Seroprevalence and determinants of toxoplasmosis in pregnant women attending antenatal clinic at the university teaching hospital, Lusaka, Zambia. BMC infectious diseases, 17(1), 1-8.
Wang, Y., Wang, G., Ou, J., Yin, H., & Zhang, D. (2014). Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4. Parasites & vectors, 7(1), 1-8.
Andiappan, H., Nissapatorn, V., Sawangjaroen, N., Nyunt, M. H., Lau, Y. L., Khaing, S. L., ... & bin Mat Adenan, N. A. (2014). Comparative study on Toxoplasma infection between Malaysian and Myanmar pregnant women. Parasites & vectors, 7(1), 1-8.
Awoke, K., Nibret, E., & Munshea, A. (2015). Sero-prevalence and associated risk factors of Toxoplasma gondii infection among pregnant women attending antenatal care at Felege Hiwot Referral Hospital, northwest Ethiopia. Asian Pacific journal of tropical medicine, 8(7), 549-554.
Abamecha, F., & Awel, H. (2016). Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia. BMC infectious diseases, 16(1), 1-8.
Cong, W., Dong, X. Y., Meng, Q. F., Zhou, N., Wang, X. Y., Huang, S. Y., ... & Qian, A. D. (2015). Toxoplasma gondii infection in pregnant women: a seroprevalence and case-control study in Eastern China. BioMed research international, 2015.
Andiappan, H., Nissapatorn, V., Sawangjaroen, N., Chemoh, W., Lau, Y. L., Kumar, T., ... & Chandeying, V. (2014). Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand. Parasites & vectors, 7(1), 1-7.
Andiappan, H., Nissapatorn, V., Sawangjaroen, N., Khaing, S. L., Salibay, C. C., Cheung, M. M. M., ... & Mat Adenan, N. A. (2014). Knowledge and practice on Toxoplasma infection in pregnant women from Malaysia, Philippines, and Thailand. Frontiers in microbiology, 5, 291.
Aqeely, H., El-Gayar, E. K., Perveen Khan, D., Najmi, A., Alvi, A., Bani, I., ... & Elhassan, I. M. (2014). Seroepidemiology of Toxoplasma gondii amongst pregnant women in Jazan Province, Saudi Arabia. Journal of tropical medicine, 2014.
Chandra, P., Mk, U., Ke, V., Mukhopadhyay, C., & U, D. A. (2021). Antimicrobial resistance and the post antibiotic era: better late than never effort. Expert opinion on drug safety, (just-accepted).
Ray, J., Ghosh, R., Paul, R., & Bandyopadhyay, D. (2019). Antibiotic Resistance Pattern of Community Acquired infections in Diabetic Subjects: A Clinico-microbiological Study from Eastern India. Journal, Indian Academy of Clinical Medicine, 20(2).
Khalighinejad, P., Alavian, S. M., Fesharaki, M. G., & Jalilianhasanpour, R. (2019). Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis. The Turkish Journal of Gastroenterology, 30(1), 66.
Dimech, W. (2021). The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases. Clinical Microbiology Reviews, 34(4), e00035-21.